Skip to content
SmartWinsNetwork

The Zimbabwean Government Declines ‘One-Sided’ US Health Aid Deal Because of Information Apprehensions

Health funding image
The offered American financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a major US health deal worth 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive biological samples.

This move was revealed after a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".

A government spokesman later explained that the US was seeking biological samples for scientific study and commercial gain while refused to share the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has called for more negotiations to find a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.

Broader Implications

Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US following legal challenges were filed about the security of Kenyans' medical information.

Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to boost openness and accountability.

As per reports, Sixteen nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in committed funds.

Specifics of the Declined Deal

This assistance for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," his statement read.

"Effectively, our nation would supply the raw materials for medical research without any certainty that the resulting innovations would be available to our population if a future disease outbreak emerge."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems previously set up through the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.

"This mechanism is intended to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."

These objections regarding the US deal "are not meant as hostility towards the US," he added.

"We are open to continued dialogue with our American counterparts on how future co-operation could be designed in a way that respects the independence and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that talks must proceed since much of the nation's HIV programmes were funded by foreign aid.

"In cases where technical issues exist, including those relating to information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it said.

The situation highlights the complex tensions between receiving vital international aid and safeguarding local interests in an ever more data-driven world.

Written by

Daniel Moore

Liam Hendricks is a seasoned financial analyst and blogger with over a decade of experience in investment strategies and wealth building.

SmartWinsNetwork

Type to search articles.